{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lincoln",
      "state": "NE",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "65422",
      "recalling_firm": "Novartis Consumer Health",
      "address_1": "10401 Hwy 6",
      "address_2": "N/A",
      "postal_code": "68517-9626",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide, Puerto Rico, Brazil and Panama",
      "recall_number": "D-846-2013",
      "product_description": "Parsel Plus (reference US product: Excedrin Tension Headache)  (Acetaminophen 500 mg and Caffeine 65 mg), packaged in 2-count pouches, Distributed by Novartis Consumer Health, Inc., USA and Novartis Consumer Health S.A., Brazil, for Novartis de Venezuela.      The foreign packaging do not have NDC number    This product was only distributed to Novartis Brazil by the recalling firm",
      "product_quantity": "472,000 pouches",
      "reason_for_recall": "Defective container: products are packaged in pouches which may not have been fully sealed",
      "recall_initiation_date": "20130606",
      "center_classification_date": "20130806",
      "termination_date": "20141104",
      "report_date": "20130814",
      "code_info": "Lot # 10121996, Exp 7/13"
    }
  ]
}